lenalidomide,tafasitamab
morphosys,incyte
['tafasitamab', 'dlbcl', 'l-mind', 'morphosys', 'incyte']
l-mind study shows prolonged, durable responses in r/r dlbcl patients treated with tafasitamab #aacr23
Onco’Zine reports about current research and development in hematology and oncology.